GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Daan Gene Co Ltd (SZSE:002030) » Definitions » Net Income (Discontinued Operations)

Daan Gene Co (SZSE:002030) Net Income (Discontinued Operations) : ¥0.0 Mil (TTM As of Mar. 2025)


View and export this data going back to 2004. Start your Free Trial

What is Daan Gene Co Net Income (Discontinued Operations)?

Net Income (Discontinued Operations) indicates the net income that a firm brought in from operations that will not be used in future reporting periods. Daan Gene Co's Net Income (Discontinued Operations) for the three months ended in Mar. 2025 was ¥0.0 Mil. Its Net Income (Discontinued Operations) for the trailing twelve months (TTM) ended in Mar. 2025 was ¥0.0 Mil.

Daan Gene Co Net Income (Discontinued Operations) Historical Data

The historical data trend for Daan Gene Co's Net Income (Discontinued Operations) can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Daan Gene Co Net Income (Discontinued Operations) Chart

Daan Gene Co Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Net Income (Discontinued Operations)
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - - -

Daan Gene Co Quarterly Data
Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25
Net Income (Discontinued Operations) Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Daan Gene Co Net Income (Discontinued Operations) Calculation

Net Income (Discontinued Operations) indicates the net income that a firm brought in from operations that will not be used in future reporting periods.

Net Income (Discontinued Operations) for the trailing twelve months (TTM) ended in Mar. 2025 adds up the quarterly data reported by the company within the most recent 12 months, which was ¥0.0 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Daan Gene Co Net Income (Discontinued Operations) Related Terms

Thank you for viewing the detailed overview of Daan Gene Co's Net Income (Discontinued Operations) provided by GuruFocus.com. Please click on the following links to see related term pages.

Daan Gene Co Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Daan Gene Co Ltd (SZSE:002030) » Definitions » Net Income (Discontinued Operations)
Comparable Companies
SHSE:688136 SHSE:688105 SHSE:605116 SZSE:300049 SZSE:300204 SHSE:600201 SHSE:688526 SZSE:000990 SHSE:688639 SZSE:301047 VRTX ASX:CSL REGN XKRX:207940 ALNY XBRU:ARGX XBRU:UCB ONC XKRX:068270 BNTX
Traded in Other Exchanges
N/A
Address
No.19 Xiangshan Road, Science Park, High & New Technology Development District, Guangdong, Guangzhou, CHN, 510665
Website
https://www.daangene.com
Daan Gene Co Ltd is a high-tech enterprise-oriented in molecular diagnostic techniques. It is primarily committed to research and development, production, and service of in-vitro diagnostic products, including qPCR, Sequeacing, TRF, ELISA, and Liquid-Based Cytology diagnostic kits and equipment. Geographically, tahe group operates in China.
Executives
Zhou Xin Yu Directors, executives
He Yun Shao Director
Huang Ru Hui Supervisors
Cheng Gang Directors, executives
Xu Qing Supervisors
He Li Xin Supervisors

Daan Gene Co Headlines

No Headlines